文献速递眼底病与葡萄膜炎

镰状细胞视网膜病变进展的预测因素:美国队列纵向评估

Predictive Factors for Progression in Sickle Cell Retinopathy: Longitudinal Evaluation of a United States Cohort.
PubMed 文献 · Am J Ophthalmol · 2026-07-20

该回顾性队列研究纳入317例镰状细胞视网膜病变患者的620只眼,采用Goldberg分期评估,Cox比例风险模型分析进展相关因素。基线非增殖期患眼进展率为10.7%,基线增殖期高危眼为17.0%;诊断增殖期时活跃吸烟与进展至更晚期显著相关(HR 2.78,95%CI 1.50-5.16)。

要点

  • 基线非增殖期患眼进展率10.7%,增殖期高危眼17.0%。
  • 诊断增殖期时活跃吸烟与进展至更晚期显著相关(HR 2.78)。
  • 年龄、性别、基因型、羟基脲等未显示与进展相关。

核心结论

  • 基线增殖期队列进展率较高,支持早期转诊和纵向眼科监测。
  • 诊断增殖期时活跃吸烟与后续进展强相关,支持戒烟建议及更密切监测。

研究设计与样本

  • 回顾性队列研究,纳入2013年7月1日至2023年6月30日期间在Wilmer眼科研究所视网膜科就诊的317例镰状细胞视网膜病变患者(620只眼)。
  • 从电子病历回顾提取人口学和临床病史,使用荧光素血管造影或超广角眼底照相进行Goldberg分期,采用Cox比例风险模型评估进展相关因素。

主要发现

  • 基线非增殖期患眼进展率为10.7%(中位随访7.8年),基线增殖期高危眼进展率为17.0%(中位随访11.1年)。
  • 诊断增殖期时活跃吸烟与进展至更晚期增殖期显著相关(风险比[95%置信区间]为2.78[1.50-5.16])。
  • 诊断时年龄、性别、基因型、羟基脲使用、输血、慢性红细胞置换、骨髓移植及终生吸烟史与进展无关。
  • 黄斑光学相干断层扫描定性评估与基线周边血管分期不相关,且与进展无关。

关键数值与推荐

  • 进展定义为从基线非增殖期进展至增殖期,或从基线增殖期进展至更晚期增殖期。
  • 吸烟暴露定义为诊断增殖期时活跃吸烟。

临床怎么用

  • 对基线增殖期患者应早期转诊并加强纵向眼科监测。
  • 对诊断增殖期时活跃吸烟者应建议戒烟,并给予更密切监测和及时干预。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To estimate progression rates in sickle cell retinopathy (SCR) and identify risk factors associated with progression. DESIGN: Retrospective Cohort Study. PARTICIPANTS: Patients with SCR (317 patients; 620 eyes) seen at the Retina Division of the Wilmer Eye Institute at least once between July 1, 2013 and June 30, 2023. METHODS: Demographics and clinical history were retrospectively extracted from electronic medical records. Goldberg staging of SCR was performed using fluorescein angiography or ultra-widefield fundus photography. Cox-proportional hazards models were used to evaluate factors associated with progression. MAIN OUTCOME MEASURES: Progression from baseline nonproliferative sickle retinopathy (NPSR) to proliferative sickle retinopathy (PSR), and from baseline PSR to more advanced PSR. RESULTS: Progression occurred in 10.7% of baseline NPSR eyes and 17.0% of at-risk baseline PSR eyes (median follow-up, 7.8 and 11.1 years, respectively). Active smoking at PSR diagnosis was significantly associated with progression to more advanced PSR (hazard ratio [95% confidence interval], 2.78 [1.50-5.16]). Age at diagnosis, sex, genotype, hydroxyurea use, blood transfusions, chronic red cell exchanges, bone marrow transplantation, and lifetime smoking history were not associated with SCR progression. Qualitative assessment of macular optical coherence tomography findings did not correlate with baseline peripheral vascular stage and were not associated with SCR progression. CONCLUSIONS: The higher progression rate within the baseline PSR cohort supports early referral and longitudinal ophthalmic surveillance for these patients. The strong association between active smoking at PSR diagnosis and subsequent progression supports recommendations for smoking cessation and closer monitoring with timely intervention among active smokers with PSR.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Agrawal A, Cardakli N, Zhang W, et al. Predictive Factors for Progression in Sickle Cell Retinopathy: Longitudinal Evaluation of a United States Cohort. Am J Ophthalmol. 2026. PMID: 42476435. doi:10.1016/j.ajo.2026.07.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。